Hippokration Hospital

The medical center is at the forefront of gastroenterology research, focusing on innovative treatments for conditions such as ulcerative colitis. Through clinical trials, the center evaluates the efficacy of novel therapies aimed at inducing remission and maintaining long-term health in pediatric and adult patients.

• Ulcerative Colitis
• Primary Biliary Cholangitis
• Erosive Esophagitis

By advancing therapeutic options, the center contributes significantly to improving the quality of life for patients with chronic gastrointestinal disorders.

Specializing in rheumatology and autoimmune diseases, the center conducts extensive research on systemic lupus erythematosus (SLE) and Sjögren’s syndrome. The focus is on developing treatments that reduce disease activity and improve patient outcomes.

• Systemic Lupus Erythematosus (SLE)
• Sjögren’s Syndrome
• Giant Cell Arteritis

Through these efforts, the center is paving the way for more effective management of complex autoimmune conditions.

The center is a leader in cardiology research, particularly in the treatment of heart failure and hypertrophic cardiomyopathy. By exploring new pharmacological interventions, the center aims to reduce cardiovascular events and improve heart function.

• Heart Failure
• Hypertrophic Cardiomyopathy
• Arterial Hypertension

These advancements are crucial in addressing the growing burden of heart diseases worldwide.

In the field of nephrology, the center is dedicated to improving outcomes for patients with chronic kidney disease and related conditions. Research efforts focus on innovative therapies that slow disease progression and enhance renal function.

• Chronic Kidney Disease
• IgA Nephropathy
• Focal Segmental Glomerulosclerosis

These studies are instrumental in developing new standards of care for kidney health.

The center's hematology research is focused on advancing treatments for blood disorders such as sickle cell disease and thalassemia. By investigating novel therapeutic agents, the center aims to improve patient survival and quality of life.

• Sickle Cell Disease
• Thalassemia
• Hemophilia A

These efforts are crucial in providing new hope for patients with hereditary blood disorders.

In endocrinology, the center is pioneering research on metabolic disorders, including diabetes and Cushing's syndrome. The focus is on developing therapies that manage symptoms and prevent complications.

• Diabetes Mellitus
• Cushing's Syndrome
• Non-alcoholic Steatohepatitis (NASH)

These studies are vital in addressing the global challenge of metabolic health.